The Gross Margin of Innocan Pharma Corp (INNO.CN) is 88.96%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 88.96% |
| 2023-12-31 | 87.71% |
| 2022-12-31 | 82.34% |
| 2021-12-31 | 61.73% |
| 2020-12-31 | 37.50% |